Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus

Open Access

Peer-reviewed

Research Article

Edmund A. Rossi,

Affiliations Immunomedics, Inc., Morris Plains, New Jersey, United States of America, IBC Pharmaceuticals, Inc., Morris Plains, New Jersey, United States of America
⨯
Chien-Hsing Chang,

Affiliations Immunomedics, Inc., Morris Plains, New Jersey, United States of America, IBC Pharmaceuticals, Inc., Morris Plains, New Jersey, United States of America
⨯
David M. Goldenberg

* E-mail: dmg.gscancer@att.net

Affiliations Immunomedics, Inc., Morris Plains, New Jersey, United States of America, IBC Pharmaceuticals, Inc., Morris Plains, New Jersey, United States of America, Center for Molecular Medicine and Immunology, Morris Plains, New Jersey, United States of America
⨯

Reader Comments (0)

B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Autoimmune diseases
Is the Subject Area "Autoimmune diseases" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Daudi cells
Is the Subject Area "Daudi cells" applicable to this article?

Thanks for your feedback.
Monocytes
Is the Subject Area "Monocytes" applicable to this article?

Thanks for your feedback.
Systemic lupus erythematosus
Is the Subject Area "Systemic lupus erythematosus" applicable to this article?

Thanks for your feedback.